fastGEN - A breakthrough system for a one-step NGS library preparation

fastGEN - A breakthrough system for a one-step NGS library preparation

Molecular Diagnostic Tests
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation
fastGEN - A breakthrough system for a one-step NGS library preparation

Information

BioVendor introduces the fastGEN technology for the examination of mutation status of oncomarkers in clinical samples. The technology is based on ultra-deep sequencing of short amplicons generated by a single polymerase chain reaction using specially tagged hybrid primers. The fastGEN technology is simple, ultra-sensitive, specific, and efficient. It is perfectly adapted for diagnostic applications and offers significant advantages for the analysis of clinical material. We offer user-friendly diagnostic kits, supported by a dedicated software solution, targeting the KRAS, NRAS, BRAF, EGFR, IDH1/2, CFTR, POLE/CTNNB1, PIK3CA, TERT, TP53, JAK2, CALR, MPL genes, as well as the BCR::ABL1 fusion gene, with excellent analytical performance and extremely fast turnaround time. The GENOVESA fastGEN module is a cloud-based, all-in-one software solution for the analysis of raw sequencing data (FASTQ files), including technical and application support.
BioVendor - Laboratorní medicína a.sS1.A39We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network. Our portfolio is structured around two complementary diagnostic pillars: Immunodiagnostics We provide a broad immunodiagnostic portfolio covering routine and specialized laboratory testing across key technologies. CLIA - Markers in autoimmunity, diabetes, gastrointestinal diseases and Infectious serology, available exclusively on the KleeYa ® platform, expanding testing possibilities MBA - Precision multiplex diagnostics for comprehensive antibody detection in autoimmune and infectious diseases. BLOT - Reliable, robust technology for precise detection of specific antibodies. ELISA - Complete portfolio for Infectious serology, immunology & endocrinology. RIA/IRMA - Proved radioimmunoassays for endocrinology including unique niche parameters. Antibodies - The foundation of immunoassays, driving performance across every diagnostic technology. Molecular Diagnostics In molecular diagnostics, BioVendor Group delivers solutions ranging from PCR-based assays to high-precision next-generation sequencing (NGS). RealFast™️ Assay - IVDR certified real-time PCR assays for rapid detection of clinically relevant genetic variants and CNVs, covering CVD and pharmacogenetics. StripAssay® - IVDR certified multiplex PCR and hybridization-based assays for simultaneous detection of clinically relevant genetic variants, covering Thalassemia and Cystic Fibrosis. NGS Assay - Targeted sequencing for oncology, hereditary diseases, and microbiome analysis with integrated bioinformatics. fastGEN™ - One-step PCR NGS library preparation for challenging oncology samples, including bioinformatic analysis. BioVendor Group - a group of companies (BioVendor LM, BioVendor R&D, TestLine, ViennaLab, DiaSource, BioVendor MDx)

Log in

See all the content and easy-to-use features by logging in or registering!